The effects of thiazolidinediones on blood pressure levels - a systematic review.
about
Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionCan the electrophysiological action of rosiglitazone explain its cardiac side effects?Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy.Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function.Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update.Sildenafil does not enhance but rather attenuates vasorelaxant effects of antidiabetic agents.Thiazolidinediones and cardiovascular risk - a question of balance.PPAR-γ agonism for cardiovascular and renal protection.Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.Revitalization of pioglitazone: the optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor.A review of chemical therapies for treating diabetic hypertension.Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction.Peroxisome proliferator-activated receptor-γ agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats.Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs.2007 ESH‐ESC Guidelines for the management of arterial hypertension
P2860
Q34231611-B09AF0F9-6667-4DDF-9A78-B9E558298E84Q36032128-1CAA815B-56CB-498C-8759-4DB9AD7C53CEQ36047253-5A72F663-5CC8-49B5-9D52-ADD919765CB4Q36159034-69BE933D-AB10-466B-BB84-A57C7D775303Q37142138-93D5F326-04DC-4734-BC8E-BF2D0302F28FQ37472745-451DF8E6-8382-440B-B4CB-8E6B33983BE0Q37777027-FDEF2B6B-49BA-41F6-886D-3F8F3C43212FQ37788729-DDE77ABA-0C08-4942-B74A-929A1E6C4795Q38524435-9E973E8F-1067-491B-81E6-20FBB7ABABCDQ38751451-78A2C6FD-C676-4E7A-89E2-B35874700F6FQ39290260-7F212EC3-AD7D-44AF-9527-77FE2AF3B840Q39418202-C1CF3D21-FE8B-403F-A7D9-0A4068BC04DAQ45839734-93A3591B-7DC9-4A1D-A3A3-9220FD21C5AEQ48365312-0FADAF67-85D7-41E6-9656-470135544428Q55564359-BA4AEC77-BEE0-41D3-96EF-DB3CB0B56B08Q56970799-EF795066-2C91-440D-8E3E-63314D968FE7
P2860
The effects of thiazolidinediones on blood pressure levels - a systematic review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The effects of thiazolidinediones on blood pressure levels - a systematic review.
@ast
The effects of thiazolidinediones on blood pressure levels - a systematic review.
@en
type
label
The effects of thiazolidinediones on blood pressure levels - a systematic review.
@ast
The effects of thiazolidinediones on blood pressure levels - a systematic review.
@en
prefLabel
The effects of thiazolidinediones on blood pressure levels - a systematic review.
@ast
The effects of thiazolidinediones on blood pressure levels - a systematic review.
@en
P2860
P1433
P1476
The effects of thiazolidinediones on blood pressure levels - a systematic review.
@en
P2093
Pantelis A Sarafidis
Peter M Nilsson
P2860
P304
P356
10.1080/08037050600853720
P577
2006-01-01T00:00:00Z